deltatrials
Completed NA NCT00150098

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

Project UNITY - A Randomized Trial of Enhanced HIV Risk Reduction and Vaccine Education Interventions in Reducing Sexual Risk and Increasing Vaccine Trial Knowledge Among HIV-negative, High-risk Women Who Use Non-injection Drugs

Sponsor: New York Blood Center

Conditions HIV Infections Hepatitis B
Interventions Enhanced HIV risk reduction and HIV vaccine education
Updated 6 times since 2017 Last updated: Apr 7, 2014 Started: Feb 28, 2005 Primary completion: Nov 30, 2009 Completion: Oct 31, 2010

Listed as NCT00150098, this NA trial focuses on HIV Infections and Hepatitis B and remains completed. Sponsored by New York Blood Center, it has been updated 6 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • New York Blood Center
  • Rutgers University
  • The New York Academy of Medicine
Data source: New York Blood Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States
  • • The Bronx, United States